NCT01033032 2022-05-03Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast CancerSCRI Development Innovations, LLCPhase 1/2 Completed78 enrolled 15 charts
NCT00380835 2008-09-23Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast CancerCelgenePhase 2 Withdrawn66 enrolled